ROCHE OMNI S 03337154001

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-03-01 for ROCHE OMNI S 03337154001 manufactured by Roche Diagnostics.

Event Text Entries

[68766224] This event occurred in (b)(6). (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[68766225] The customer stated that they received an erroneous result for one newborn patient sample tested for bilirubin on a cobas b 221<6>=roche omni s6 system (b221). The issue was encountered only with this one sample. A capillary sample from the patient was tested on the b221 analyzer, resulting as 16. 3 mg/dl. After this high result, the customer prepared 3 additional samples from the patient; one capillary sample for testing on the b221 analyzer, one for testing on a bilirubinometer, and one venous sample for testing in the central laboratory. The sample tested on the bilirubinometer resulted as 12. 7 mg/dl. The sample tested in the central laboratory resulted as 13. 57 mg/dl. The sample tested on the b221 analyzer confirmed the previous high result of 16. 3 mg/dl. All controls recovered ok. It was also stated that the "cuvette" was replaced and calibrated, with controls recovering ok. The patient was not adversely affected.
Patient Sequence No: 1, Text Type: D, B5


[69978578]
Patient Sequence No: 1, Text Type: N, H10


[71848256]
Patient Sequence No: 1, Text Type: N, H10


[75261211] Data provided from the analyzer showed no indication of analyzer related problems. There were no indications in the calibration data of an analyzer related problem. All quality control results were within range and did not indicate an analyzer related problem. The issue was determined to be related to a pre-analytic sample handling issue. No other issues with bilirubin on the cobas b221 analyzer have been reported within the past year.
Patient Sequence No: 1, Text Type: N, H10


[78487057] Based upon medical assessment, all results that were obtained indicated hyperbilirubinemia. In newborns older than 3 days, only levels >20mg/dl or >25mg/dl are likely to lead to immediate phototherapy or consideration of exchange transfusion. No medical risk is likely in this case.
Patient Sequence No: 1, Text Type: N, H10


[132589492] Medwatch has been updated.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2017-00442
MDR Report Key6369981
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-03-01
Date of Report2018-04-04
Date of Event2017-02-10
Date Mfgr Received2017-02-11
Date Added to Maude2017-03-01
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameROCHE OMNI S
Generic NameBLOOD GAS ANALYZER
Product CodeJJC
Date Received2017-03-01
Model NumberNA
Catalog Number03337154001
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2017-03-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.